Image

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

Studying Cancer Detection and Monitoring Using Blood Tests

Recruiting
40-75 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates early cancer detection and treatment response monitoring in cancer patients. It focuses on identifying specific RNA markers in platelets and immune cells to distinguish cancer patients from healthy individuals.

The study evaluates the safety and effectiveness of an AI-based blood test. It uses non-invasive methods to enhance cancer diagnosis and monitor treatment responses over time.

  • Who can participate: Adults aged 40 years or older with confirmed diagnoses of certain common cancers can participate. Participants should not be pregnant or have active infectious diseases.
  • Study details: Participants will provide blood samples for RNA analysis to identify biomarkers.
  • Study timelines and visits: The study will last 6 months. The study requires 3 visits.
Print
Study details
    Brest Cancer
    Lung Cancer (NSCLC)
    Pancreatic Cancer
    Adult
    Prostate Cancers
    Ovarian Cancer
    Colorectal Cancer
    Glioblastoma (GBM)
    Liver Carcinoma

NCT06717295

Javier Toledo

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.